Serologic evidence of human monocytic and granulocytic ehrlichiosis in Israel

被引:33
作者
Keysary, A
Amram, L
Keren, G
Sthoeger, Z
Potasman, I
Jacob, A
Strenger, C
Dawson, JE
Waner, T
机构
[1] Israel Inst Biol Res, IL-70400 Ness Ziona, Israel
[2] Asaf Harofe Med Ctr, Tzrifin, Israel
[3] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
[4] Kaplan Hosp, IL-76100 Rehovot, Israel
[5] Bnei Zion Med Ctr, Haifa, Israel
[6] Schneider Childrens Med Ctr Israel, Petah Tiqwa, Israel
[7] Ctr Dis Control & Prevent, Atlanta, GA USA
关键词
D O I
10.3201/eid0506.990605
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We conducted a retrospective serosurvey of 1,000 persons in Israel who had fever of undetermined cause to look for Ehrlichia chaffeensis antibodies. Four of five cases with antibodies reactive to E. chaffeensis were diagnosed in the summer, when ticks are more active. All patients had influenzalike symptoms with high fever. None of the cases was fatal. Three serum samples were also seroreactive for antibodies to E. canis, and one was also reactive to the human granulocytic ehrlichiosis (HGE) agent. The titer to the HGE agent in this patient was higher than the serum titer to E. chaffeensis, and the Western blot analysis also indicated that the HGE agent was the primary cause of infection. We present the first serologic evidence that the agents of human monocytic ehrlichiosis (HME) and HGE are present in Israel. Therefore, human ehrlichiosis should be included in the differential diagnoses for persons in Israel who have been exposed to ticks and have influenzalike symptoms.
引用
收藏
页码:775 / 778
页数:4
相关论文
共 13 条
[1]  
Arraga-Alvarado C, 1996, Invest Clin, V37, P35
[2]   Serological evidence of human granulocytic ehrlichiosis in Norway [J].
Bakken, JS ;
Krueth, J ;
Tilden, RL ;
Dumler, JS ;
Kristiansen, BE .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (10) :829-832
[3]   HUMAN GRANULOCYTIC EHRLICHIOSIS IN EUROPE [J].
BROUQUI, P ;
DUMLER, JS ;
LIENHARD, R ;
BROSSARD, M ;
RAOULT, D .
LANCET, 1995, 346 (8977) :782-783
[4]   SEROLOGIC EVIDENCE FOR HUMAN EHRLICHIOSIS IN AFRICA [J].
BROUQUI, P ;
LECAM, C ;
KELLY, PJ ;
LAURENS, R ;
TOUNKARA, A ;
SAWADOGO, S ;
VELOMARCEL ;
GONDAO, L ;
FAUGERE, B ;
DELMONT, J ;
BOURGEADE, A ;
RAOULT, D .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1994, 10 (06) :695-698
[5]   SEROLOGIC CROSS-REACTIONS AMONG EHRLICHIA-EQUI, EHRLICHIA-PHAGOCYTOPHILA, AND HUMAN GRANULOCYTIC EHRLICHIA [J].
DUMLER, JS ;
ASANOVICH, KM ;
BAKKEN, JS ;
RICHTER, P ;
KIMSEY, R ;
MADIGAN, JE .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (05) :1098-1103
[6]  
DUMLER JS, 1997, RICKETTSIAL INFECT I, P149
[7]   The first isolation, in vitro propagation, and genetic characterization of Ehrlichia canis in Israel [J].
Keysary, A ;
Waner, T ;
Rosner, M ;
Warner, CK ;
Dawson, JE ;
Zass, R ;
Biggie, KL ;
Harrus, S .
VETERINARY PARASITOLOGY, 1996, 62 (3-4) :331-340
[8]  
MORAIS JD, 1991, LANCET, V338, P633, DOI 10.1016/0140-6736(91)90644-5
[9]  
REED KD, 1995, JAMA-J AM MED ASSOC, V273, P23, DOI 10.1001/jama.273.1.23b
[10]  
THEODOR O, 1997, ECTOPARASITES SURV 1, P92